Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
James M. Cook
James M. Cook, Tucson, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20100327106 | System and Method for Attitude Control of a Flight Vehicle using Pitch-Over Thrusters - A reliable and inexpensive attitude control system uses a plurality of pitch-over thrusters to perform rapid and precise attitude maneuvers for a flight vehicle. The pitch-over thrusters create rotational moments that directly pitch and yaw the flight vehicle. The use of very simple thrusters and control techniques provides for a reliable and cost effective solution. The ability to perform overlapping pitch and yaw maneuvers with single-shot fixed-impulse thrusters provides for high-speed maneuverability. | 12-30-2010 |
| 20110049289 | METHOD OF CONTROLLING MISSILE FLIGHT USING ATTITUDE CONTROL THRUSTERS - A method of controlling flight of a missile includes using gyroscopes, such as pitch rate gyroscopes, to sense when a factor based on the angular rate of change of the missile exceeds a threshold value. One the threshold value is exceeded, a decision may be made to use one or more compensation thrusters to reduce the angular rate of change. The use of the compensation thrusters may correct residual angular velocities from a pitch over maneuver used to put the missile on an intended course. In addition, the compensation thrusters may be used to compensate for errors in missile heading induced after the pitch over maneuver, such as induced by misalignment of thrust provided by a main rocket motor of the missile. Multiple compensation thrusters may be used to compensate for angular changes in the pitch and yaw directions. | 03-03-2011 |
James M. Cook, Milwaukee, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090281109 | CYSTEINE AND CYSTINE PRODRUGS TO TREAT SCHIZOPHRENIA AND REDUCE DRUG CRAVINGS - The present invention provides cysteine and cystine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction. | 11-12-2009 |
| 20100048587 | CYSTEINE AND CYSTINE BIOISOSTERES TO TREAT SCHIZOPHRENIA AND REDUCE DRUG CRAVINGS - The present invention provides cysteine and cystine bioisosteres for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing such bioisosteres and methods of using the bioisosteres for treatment of schizophrenia and drug addiction. | 02-25-2010 |
| 20110021533 | CYSTEINE PRODRUGS TO TREAT SCHIZOPHRENIA AND DRUG ADDICTION - The present invention provides cysteine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction. | 01-27-2011 |
James M. Cook, Whitefish Bay, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090306121 | AZA-BETA-CARBOLINES AND METHODS OF USING SAME - Provided are compounds having the general structure according to Formula (I): | 12-10-2009 |
| 20100004226 | STEREOSPECIFIC ANXIOLYTIC AND ANTICONVULSANT AGENTS WITH REDUCED MUSCLE-RELAXANT, SEDATIVE-HYPNOTIC AND ATAXIC EFFECTS - The present invention provides compositions and methods of using stereospecific benzodiazepine derivatives, their salts and prodrugs for the treatment of anxiolytic or convulsant disorders having the side effects of reduced alcohol craving in human alcoholics and a concomitant reduced sedative, hypnotic, muscle relaxant and ataxic side-effects. The invention further provides pharmaceutical compositions for treatment of anxiolytic and convulsant disorders in subjects in need thereof, comprising a compound, prodrug or a salt having a chemical structure represented by any one of Formula I-IV, VI-XI, XV-XVIII and XX-XXI and a pharmaceutically-acceptable carrier. | 01-07-2010 |
| 20100130479 | Gabaergic Agents to Treat Memory Deficits - The present invention provides molecules and methods for the prevention and/or treatment of memory deficit related conditions and/or enhancement of cognition. In a preferred embodiment, the invention includes compounds, salts and prodrugs thereof for the prevention and/or treatment of these conditions. | 05-27-2010 |
| 20100261711 | SELECTIVE ANTICONVULSANT AGENTS AND THEIR USES - In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of seizures. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of seizures with reduced sedative and ataxic side effects. | 10-14-2010 |
James M. Cook US
| Patent application number | Description | Published |
|---|---|---|
| 20100130481 | ANTICONVULSANT AND ANXIOLYTIC METHODS OF USING RECEPTOR SUBTYPE SELECTIVE AGENTS - Methods of using orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anticonvulsant and anxiolytic activity with reduced sedative, hypnotic, muscle relaxant, or ataxic effects. | 05-27-2010 |